This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Seonyoung Yang: Innovator in Protein-Based Medicines
Introduction
Seonyoung Yang is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein-based medicines. His innovative work focuses on enhancing the efficacy of treatments for liver diseases associated with viral infections.
Latest Patents
Seonyoung Yang holds a patent for an invention titled "Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP)." This patent describes a fused protein that combines IFN-α with a CTP, which facilitates the translocation of the protein into liver cells. The invention aims to improve the conjugation capacity of cell membranes and enhance antiviral activity while minimizing transport into the cell nucleus. This advancement has the potential to lead to the development of effective protein-based medicines for treating various liver diseases at low doses.
Career Highlights
Yang is associated with Jw Pharmaceutical Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His research and development efforts are focused on creating therapies that can significantly impact patient care and treatment outcomes.
Collaborations
Seonyoung Yang collaborates with notable colleagues, including Chan Kyu Lee and Eun Ju Kang. Their combined expertise contributes to the advancement of research and development in the field of biotechnology.
Conclusion
Seonyoung Yang's contributions to the field of protein-based medicines highlight his role as an innovator in biotechnology. His patented work on IFN-α fused proteins represents a significant step forward in the treatment of liver diseases.